Luke Selth

20PUBLICATIONS
114CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisMedical molecular engineering of nucleic acids and proteinsCell and nuclear division
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 02, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer.

|Mar 25, 2026
Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy-Naïve Localized Prostate Cancer.

Eva Apostolov, Daniel L Roden, Holly Holliday

|Oct 14, 2025
Protein disulfide isomerases regulate androgen receptor stability and promote prostate cancer cell growth and survival.

Jianling Xie, Kaikai Shen, Wenken Liang

|Nov 08, 2024
Friend or foe? Deciphering androgen receptor action to improve bipolar androgen therapy for prostate cancer.

Samuel P G Rollin, Mitchell G Lawrence, Anthony M Joshua

|Aug 08, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson

|Jun 08, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.

Zifeng Wang, Scott L Townley, Songqi Zhang

Pageof 4

Frequent Collaborators

10 joint publications

Lisa M Butler

8 joint publications

Wayne Tilley

5 joint publications

Jianling Xie

4 joint publications

Zeyad D Nassar